Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

accord healthcare, s.l.u. - bisoprololo - bisoprololo

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

vemedia manufacturing b.v. - altri urologici - altri urologici

Unión Europea - italiano - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

medacta italia s.r.l. - succedanei del sangue e frazioni proteiche plasmatiche - succedanei del sangue e frazioni proteiche plasmatiche

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

baxalta innovations gmbh - fattori della coagulazione del sangue - fattori della coagulazione del sangue

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

baxalta innovations gmbh - fattori della coagulazione del sangue - fattori della coagulazione del sangue

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

csl behring gmbh - fattore ix di coagulazione del sangue - fattore ix di coagulazione del sangue

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

grifols italia s.p.a. - fattore ix di coagulazione del sangue - fattore ix di coagulazione del sangue

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

industria farmaceutica galenica senese s.r.l. - prodotti ausiliari per la trasfusione del sangue - prodotti ausiliari per la trasfusione del sangue

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

s.a.l.f. spa laboratorio farmacologico - prodotti ausiliari per la trasfusione del sangue - prodotti ausiliari per la trasfusione del sangue